Organ Preservation Solutions Market Size to Hit US$ 506.3 Million, at CAGR 10.5% by 2027 | Transparency Market Research

September 06, 2023 10:07 PM AEST | By EIN Presswire
 Organ Preservation Solutions Market Size to Hit US$ 506.3 Million, at CAGR 10.5% by 2027 | Transparency Market Research
Image source: EIN Presswire

Organ preservation solution market is driven by rise in organ transplantation, aging population, and technological advancements

WILMINGTON, DELAWARE, UNITED STATES, September 6, 2023/EINPresswire.com/ -- The global Organ Preservation Solutions Market is estimated to attain a valuation of US$ 506.3 Mn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 10.5% during the forecast period, 2019-2027

The organ preservation solutions market is segmented on the basis of type, application, organ type, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐎𝐫𝐠𝐚𝐧 𝐏𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1786

The solutions used to retain organs and reduce tissue damage, particularly while they are awaiting implantation, are referred to as organ preservation solutions. Because external organs frequently collapse after being removed from the human body, they are employed to safeguard organs before transplantation.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐫𝐠𝐚𝐧 𝐏𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐚𝐧𝐝 𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

• Dr. Franz Köhler Chemie GmbH
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd
• XVIVO Perfusion AB
• BioLife Solutions, Inc.
• 21st Century Medicine
• Bridge to Life Ltd.
• Accord Healthcare
• OrganOx Limited,

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞- https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1786

𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

The market has been expanding over the past few years as a result of factors such the rising frequency of various chronic diseases, the increase in healthcare spending, the rising incidence of new cancer cases, and the increasing need for organ transplantation. Demographics for organ transplant practices include a sizable portion of the elderly population.

Additionally, the elderly age group is more susceptible to organ failures due to poor adherence to treatment, poor tolerance of medication, and the existence of underlying or related disorders. As a result, as the world's population ages, there will be a greater need for organ transplants, which in turn will fuel the expansion of the market for organ preservation technologies.

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐓𝐨 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=1786

𝐌𝐚𝐫𝐤𝐞𝐭 – 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐓𝐲𝐩𝐞

• Viaspan

• Lifor

• Custodiol HTK

• siRNA Transplant Solutions

• Renograf

• Hypothermosol

• Perfadex

• HBS Solution

• Others

𝐏𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞

• Hypothermic Perfusion Preservation

• Static Cold Storage

• Others

𝐑𝐞𝐠𝐢𝐨𝐧

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 –

Orthopedic Implants Market The worth of the global market in 2021 was estimated at US$ 34.5 Bn by 2031

Global Image-Based Cytometry in Cell Analysis Market to Reach US$ 6.5 Billion by 2031, Expanding at a CAGR of 10.4%

Nikhil Sawlani
Transparency Market Research Inc.
8665523453 ext.
[email protected]
Visit us on social media:
Twitter
LinkedIn
YouTube


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.